TDACW
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$1.85
+0.00%Price chart
Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−25.0x
Market Cap
$31.91M
MomentumView details →
1D Return
+0.00%
YTD Return
+509.68%
RSI (14)
53.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−25.0x
Market Cap
$31.91M
RSI (14)
53.5
MomentumView details →
1D Return
+0.00%
YTD Return
+509.68%
Similar companies
Columbus Circle Capital Corp IICMIIWAustralian Oilseeds Holdings Limited WarrantCOOTWIdea Acquisition Corp. UnitsIACOUJones Ventures INTL Acquisition1 Corp RightsJONERBRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred StockRILYPDT Cloud Star Acquisition CorporationDTSQFind similar companies →
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.39d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.61d ago